Empagliflozin Versus Placebo in Type 2 Diabetes and Cardiovascular Disease: A Systematic Review and Meta-Analysis
American Journal of Therapeutics | May 22, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available
10.1097/mjt.0000000000001983